Understanding Lusutrombopag: A TPO Receptor Agonist for Platelet Disorders
In the complex landscape of pharmaceutical development, understanding the precise mechanisms and applications of key compounds is paramount for researchers and procurement managers. Lusutrombopag, identified by its CAS number 1110766-97-6, has emerged as a significant molecule, particularly in the management of platelet disorders. As a leading manufacturer of high-quality pharmaceutical intermediates, NINGBO INNO PHARMCHEM is dedicated to providing insights into such critical compounds.
Lusutrombopag is recognized as an orally bioavailable thrombopoietin (TPO) receptor agonist. Its primary function is to stimulate the production of platelets in the body. This is achieved by selectively binding to and activating the TPO receptor, which in turn prompts the bone marrow to increase the production and maturation of megakaryocytes, the precursor cells for platelets. This mechanism is crucial for patients suffering from conditions characterized by low platelet counts, a state known as thrombocytopenia.
The clinical significance of Lusutrombopag is most pronounced in patients with chronic liver disease (CLD) who exhibit thrombocytopenia, especially when they are scheduled for elective invasive surgical procedures. By raising platelet levels, Lusutrombopag helps mitigate the risk of bleeding during and after surgery. This makes it an indispensable component in the treatment regimens for such patients. For procurement managers and researchers looking to buy Lusutrombopag, understanding its therapeutic role is key to ensuring the right quality and specification are obtained.
As a high-purity API and pharmaceutical intermediate, Lusutrombopag is manufactured under strict quality control measures. NINGBO INNO PHARMCHEM, as a reputable supplier of this compound from China, prioritizes purity and consistency. Our commitment to excellence means that when you purchase Lusutrombopag from us, you are assured of a product that meets the stringent demands of the pharmaceutical industry. We offer competitive pricing and reliable supply chains, ensuring that your research and production needs are met efficiently.
For those seeking a dependable manufacturer of Lusutrombopag or other advanced pharmaceutical chemicals, exploring the offerings of NINGBO INNO PHARMCHEM is a strategic step. We facilitate global access to high-quality APIs, supporting the advancement of medical treatments worldwide. Whether you are conducting research or scaling up production, our team is ready to provide the necessary technical support and product information to facilitate your purchase.
Perspectives & Insights
Data Seeker X
“By raising platelet levels, Lusutrombopag helps mitigate the risk of bleeding during and after surgery.”
Chem Reader AI
“This makes it an indispensable component in the treatment regimens for such patients.”
Agile Vision 2025
“For procurement managers and researchers looking to buy Lusutrombopag, understanding its therapeutic role is key to ensuring the right quality and specification are obtained.”